World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00529659
Date of registration: 11/09/2007
Primary sponsor: Merck
Public title: A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005)
Scientific title: A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients With Sarcopenia
Date of first enrolment: October 2007
Target sample size: 170
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00529659
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment  
Countries of recruitment
Chile Colombia Denmark Finland France Hong Kong Israel Italy
Mexico New Zealand Norway Peru South Africa Spain Sweden United Kingdom
United States
Contacts
Name:   Medical Monitor
Address: 
Telephone:
Email:
Affiliation:  Merck
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patient is a woman who is 65 years of age or older

- Patient's lean body mass is at least 1 standard deviation below the mean of a healthy
young adult population

- Patient has difficulty climbing 10 steps or walking outside on level ground for 1/4
mile without resting or Activity Measure for Post Acute Care (AM-PAC)<66

Exclusion Criteria:

- Patient has serious neurological, rheumatologic, cardiac, respiratory, kidney,
psychiatric conditions

- Patient has a history of certain types of cancer



Age minimum: 65 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Sarcopenia
Intervention(s)
Drug: Comparator: MK-0773
Drug: Comparator: Placebo
Primary Outcome(s)
Change From Baseline in Bilateral Leg Press (BLP) Measurement [Time Frame: Baseline, Month 6]
Change From Baseline in Participant Lean Body Mass [Time Frame: Baseline, Month 6]
Secondary Outcome(s)
Change From Baseline in Activity Measure for Post Acute Care (AM-PAC) Physical Movement Score [Time Frame: Baseline, Month 6]
Change From Baseline in Participant Gait Speed [Time Frame: Baseline, Month 6]
Change From Baseline in Participant Short Physical Performance Battery (SPPB) [Time Frame: Baseline, Month 6]
Change From Baseline in Stair Climbing Power [Time Frame: Baseline, Month 6]
Secondary ID(s)
2007_532
MK-0773-005
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history